Literature DB >> 34101130

A report of nonexistence of the non-Helicobacter pylori Helicobacter species in Iranian patients suffering from inflammatory bowel disease.

Samira Pirmanesh1, Nasrin Mirzaei1, Masoumeh Azimirad1, Abbas Yadegar2, John Y Kao3, Hamid Asadzadeh Aghdaei4, Mohammad Reza Zali5.   

Abstract

Inflammatory bowel disease is a chronic, relapsing-remitting gastrointestinal disorder which has become a serious global concern, and it imposes a great degree of health and economic burdens on communities worldwide. Although the presence of non-Helicobacter pylori Helicobacter (NHPH) microorganisms has been reported in various gastrointestinal disorders, their putative role in the pathogenesis of IBD has been a matter of controversy. The present study aimed to investigate the existence of gastric and enterohepatic NHPHs and their probable coinfection with H. pylori in IBD. Totally, 168 clinical specimens including 70 colonic biopsies and 98 fecal specimens were obtained from IBD patients. Genomic DNA was extracted from all samples, and its quality and concentration were assessed by β-globin PCR and spectrophotometry. The Helicobacter genus-specific PCR was performed using 16S rRNA gene. All samples were also tested for H. pylori infection by PCR of ureC gene fragment (glmM). The presence of NHPH was examined by using species-specific PCR assays. Based on PCR results, H. pylori was detected in 12.9% and 3.1% of colonic biopsies and fecal specimens, respectively. However, no statistically significant correlation was observed (P value > 0.05). We failed to find NHPH in both colonic biopsies and fecal specimens from IBD patients. Despite the fact that none of the IBD patients harbored the NHPH in the current work, further cohorts with larger sample size are required to determine the possible relationship between NHPH infection and IBD pathogenesis.

Entities:  

Keywords:  H. pylori; IBD; Inflammatory bowel disease; Iran; NHPH; Non-H. pylori Helicobacter

Year:  2021        PMID: 34101130     DOI: 10.1007/s12223-021-00883-z

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  38 in total

1.  Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease.

Authors:  Ulrich R M Bohr; Bernhard Glasbrenner; Anett Primus; Alexandra Zagoura; Thomas Wex; Peter Malfertheiner
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

2.  Does Eradication of Helicobacter Pylori Cause Inflammatory Bowel Disease?

Authors:  Johan Burisch; Tine Jess
Journal:  Clin Gastroenterol Hepatol       Date:  2019-02-12       Impact factor: 11.382

3.  Detection of non-pylori Helicobacter species in "Helicobacter heilmannii"-infected humans.

Authors:  Dominic De Groote; Leen-Jan Van Doorn; Kathleen Van den Bulck; Peter Vandamme; Michael Vieth; Manfred Stolte; Jean-Claude Debongnie; Alain Burette; Freddy Haesebrouck; Richard Ducatelle
Journal:  Helicobacter       Date:  2005-10       Impact factor: 5.753

Review 4.  The non-H pylori helicobacters: their expanding role in gastrointestinal and systemic diseases.

Authors:  J G Fox
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

5.  Helicobacter marmotae sp. nov. isolated from livers of woodchucks and intestines of cats.

Authors:  James G Fox; Zeli Shen; Shilu Xu; Yan Feng; Charles A Dangler; Floyd E Dewhirst; Bruce J Paster; John M Cullen
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

6.  Spontaneous inflammatory bowel disease in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus.

Authors:  C J Foltz; J G Fox; R Cahill; J C Murphy; L Yan; B Shames; D B Schauer
Journal:  Helicobacter       Date:  1998-06       Impact factor: 5.753

Review 7.  Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis.

Authors:  Natalia Castaño-Rodríguez; Nadeem O Kaakoush; Way Seah Lee; Hazel M Mitchell
Journal:  Gut       Date:  2015-10-27       Impact factor: 23.059

8.  Evaluation of Helicobacter species in inflammatory bowel disease.

Authors:  S J Bell; S A Chisholm; R J Owen; S P Borriello; M A Kamm
Journal:  Aliment Pharmacol Ther       Date:  2003-09-01       Impact factor: 8.171

9.  Low prevalence of Helicobacteraceae in gall-stone disease and gall-bladder carcinoma in the German population.

Authors:  U R M Bohr; D Kuester; F Meyer; T Wex; M Stillert; A Csepregi; H Lippert; A Roessner; P Malfertheiner
Journal:  Clin Microbiol Infect       Date:  2007-03-07       Impact factor: 8.067

Review 10.  The immunomodulatory properties of Helicobacter pylori confer protection against allergic and chronic inflammatory disorders.

Authors:  Isabelle C Arnold; Iris Hitzler; Anne Müller
Journal:  Front Cell Infect Microbiol       Date:  2012-02-16       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.